Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Conant

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Open Forum Infectious Diseases|January 27, 2016
Role of the Infectious Disease Consultant in Management of Patients With Tuberculosis-Associated Ocular InflammationMarjorie M Conant, Chuck R Vrasich, Jeff V Wongskhaluang, et al.
Sexually Transmitted Diseases|July 23, 1999
An interactive, computer-based program to educate patients about genital herpesC Bensen, J Stern, E Skinner, et al.
Lancet (London, England)|April 23, 1983
AIDS in the "gay" areas of San FranciscoA R Moss, P Bacchetti, M Gorman, et al.
The American Journal of Medicine|August 29, 1988
Prolonged continuous versus intermittent oral acyclovir treatment in normal adults with frequently recurring genital herpes simplex virus infectionG J Mertz, L Eron, R Kaufman, et al.
Antiviral Research|March 11, 1992
Recombinant alpha-2 interferon gel treatment of recurrent herpes genitalisM Lebwohl, S Sacks, M Conant, et al.
JAMA|January 22, 1988
Natural interferon alfa for treatment of condylomata acuminataA E Friedman-Kien, L J Eron, M Conant, et al.
The Journal of Infectious Diseases|June 2, 1998
A preliminary evaluation of nelfinavir mesylate, an inhibitor of human immunodeficiency virus (HIV)-1 protease, to treat HIV infectionM Markowitz, M Conant, A Hurley, et al.
AIDS (London, England)|April 24, 2001
Prevalence of HIV-1 drug resistance in antiretroviral-naive patients: a prospective studyW Verbiest, S Brown, C Cohen, et al.
Antimicrobial Agents and Chemotherapy|April 4, 1998
A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant human immunodeficiency virus type 1 isolates from patients treated with antiretroviral drugsK Hertogs, M P de Béthune, V Miller, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Open Forum Infectious Diseases|January 27, 2016
Role of the Infectious Disease Consultant in Management of Patients With Tuberculosis-Associated Ocular InflammationMarjorie M Conant, Chuck R Vrasich, Jeff V Wongskhaluang, et al.
Sexually Transmitted Diseases|July 23, 1999
An interactive, computer-based program to educate patients about genital herpesC Bensen, J Stern, E Skinner, et al.
Lancet (London, England)|April 23, 1983
AIDS in the "gay" areas of San FranciscoA R Moss, P Bacchetti, M Gorman, et al.
The American Journal of Medicine|August 29, 1988
Prolonged continuous versus intermittent oral acyclovir treatment in normal adults with frequently recurring genital herpes simplex virus infectionG J Mertz, L Eron, R Kaufman, et al.
Antiviral Research|March 11, 1992
Recombinant alpha-2 interferon gel treatment of recurrent herpes genitalisM Lebwohl, S Sacks, M Conant, et al.
JAMA|January 22, 1988
Natural interferon alfa for treatment of condylomata acuminataA E Friedman-Kien, L J Eron, M Conant, et al.
The Journal of Infectious Diseases|June 2, 1998
A preliminary evaluation of nelfinavir mesylate, an inhibitor of human immunodeficiency virus (HIV)-1 protease, to treat HIV infectionM Markowitz, M Conant, A Hurley, et al.
AIDS (London, England)|April 24, 2001
Prevalence of HIV-1 drug resistance in antiretroviral-naive patients: a prospective studyW Verbiest, S Brown, C Cohen, et al.
Antimicrobial Agents and Chemotherapy|April 4, 1998
A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant human immunodeficiency virus type 1 isolates from patients treated with antiretroviral drugsK Hertogs, M P de Béthune, V Miller, et al.
Pageof 6